$CAPR
CAPRICOR THERAPEUTICS, INC. Stock $capr

$capr Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000114420416101913 Filed on May 13, 2016

Income Statement

Concept	2016 Q1	2015 Q1
Revenue	$1.215M	$1.788M
YoY Change	-32.04%	71.64%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.080M	$1.400M
YoY Change	-22.86%	64.71%
% of Gross Profit
Research & Development	$4.341M	$3.807M
YoY Change	14.03%	176.93%
% of Gross Profit
Depreciation & Amortization	$31.60K	$24.80K
YoY Change	27.43%	283.63%
% of Gross Profit
Operating Expenses	$5.426M	$5.203M
YoY Change	4.29%	133.61%
Operating Profit	-$4.211M	-$3.415M
YoY Change	23.31%	188.06%
Interest Expense	$66.13K	$61.68K
YoY Change	7.2%	143.54%
% of Operating Profit
Other Income/Expense, Net	-$55.62K	-$61.41K
YoY Change	-9.43%	143.93%
Pretax Income	-$4.270M	-$3.480M
YoY Change	22.7%	187.6%
Income Tax
% Of Pretax Income
Net Earnings	-$4.266M	-$3.476M
YoY Change	22.73%	187.14%
Net Earnings / Revenue	-351.11%	-194.43%
Basic Earnings Per Share
Diluted Earnings Per Share	-$2.588M	-$2.336M
COMMON SHARES
Basic Shares Outstanding	17.95M shares	16.22M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.26M	$22.42M
YoY Change	-36.38%	68.53%
Cash & Equivalents	$11.77M	$6.939M
Short-Term Investments	$2.498M	$15.48M
Other Short-Term Assets	$320.0K	$2.250M
YoY Change	-85.78%	208.22%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$14.89M	$25.42M
YoY Change	-41.42%	81.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$345.0K	$250.0K
YoY Change	37.98%	52.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$70.00K	$70.00K
YoY Change	0.0%	40.0%
Total Long-Term Assets	$2.095M	$2.050M
YoY Change	2.2%	5.34%
TOTAL ASSETS
Total Short-Term Assets	$14.89M	$25.42M
Total Long-Term Assets	$2.095M	$2.050M
Total Assets	$16.98M	$27.47M
YoY Change	-38.17%	71.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.690M	$3.380M
YoY Change	9.17%	69.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.341M	$7.545M
YoY Change	-2.71%	19.78%
LONG-TERM LIABILITIES
Long-Term Debt	$10.16M	$9.160M
YoY Change	10.92%	131.31%
Other Long-Term Liabilities	$570.0K	$3.450M
YoY Change	-83.48%	-53.25%
Total Long-Term Liabilities	$10.73M	$12.60M
YoY Change	-14.87%	11.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.341M	$7.545M
Total Long-Term Liabilities	$10.73M	$12.60M
Total Liabilities	$18.07M	$20.15M
YoY Change	-10.32%	14.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.44M	-$25.79M
YoY Change	52.92%
Common Stock	$38.33M	$33.12M
YoY Change	15.75%	283216.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.083M	$7.325M
YoY Change
Total Liabilities & Shareholders Equity	$16.98M	$27.47M
YoY Change	-38.17%	71.94%

Cashflow Statement

Concept	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	-$4.266M	-$3.476M
YoY Change	22.73%	187.14%
Depreciation, Depletion And Amortization	$31.60K	$24.80K
YoY Change	27.43%	283.63%
Cash From Operating Activities	-$4.180M	-$2.050M
YoY Change	103.9%	-118.08%
INVESTING ACTIVITIES
Capital Expenditures	$45.81K	$27.46K
YoY Change	66.85%	-70.45%
Acquisitions
YoY Change
Other Investing Activities	$5.490M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	$5.450M	-$15.52M
YoY Change	-135.12%	17144.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$16.45M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.930M	16.48M
YoY Change	-70.08%
NET CHANGE
Cash From Operating Activities	-4.180M	-2.050M
Cash From Investing Activities	5.450M	-15.52M
Cash From Financing Activities	4.930M	16.48M
Net Change In Cash	6.200M	-1.090M
YoY Change	-668.81%	-109.69%
FREE CASH FLOW
Cash From Operating Activities	-$4.180M	-$2.050M
Capital Expenditures	$45.81K	$27.46K
Free Cash Flow	-$4.226M	-$2.077M
YoY Change	103.41%	-118.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	235830	shares
CY2016Q1	us-gaap	Other Assets OtherAssets	71146	USD
CY2015Q4	us-gaap	Assets Assets	16069572	USD
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2530500	USD
CY2016Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3224044	USD
CY2015Q4	capr	Accounts Payable And Accrued Expenses Related Party Current AccountsPayableAndAccruedExpensesRelatedPartyCurrent	352334	USD
CY2016Q1	capr	Accounts Payable And Accrued Expenses Related Party Current AccountsPayableAndAccruedExpensesRelatedPartyCurrent	470869	USD
CY2016Q1	us-gaap	Grants Receivable Current GrantsReceivableCurrent	303631	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	210603	USD
CY2016Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	321421	USD
CY2015Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	211938	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	13989857	USD
CY2016Q1	us-gaap	Assets Current AssetsCurrent	14889931	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	318566	USD
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	344957	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	191003	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	178816	USD
CY2015Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1500000	USD
CY2016Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1500000	USD
CY2015Q4	us-gaap	Other Assets OtherAssets	70146	USD
CY2016Q1	us-gaap	Assets Assets	16984850	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3645834	USD
CY2016Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3645833	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6528668	USD
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	7340746	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	911458	USD
CY2016Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	USD
CY2015Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	9155857	USD
CY2016Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	10155857	USD
CY2015Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	505363	USD
CY2016Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	571152	USD
CY2015Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10572678	USD
CY2016Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10727009	USD
CY2015Q4	us-gaap	Liabilities Liabilities	17101346	USD
CY2016Q1	us-gaap	Liabilities Liabilities	18067755	USD
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	34115052	USD
CY2016Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	38334722	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	9385	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3228	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-1031774	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	-1082905	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16069572	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16984850	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39438807	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35172466	USD
CY2016Q1	capr	Collaboration Revenue CollaborationRevenue	911458	USD
CY2015Q1	capr	Collaboration Revenue CollaborationRevenue	1041667	USD
CY2015Q1	us-gaap	Revenue From Grants RevenueFromGrants	746235	USD
CY2016Q1	us-gaap	Revenue From Grants RevenueFromGrants	303631	USD
CY2015Q1	us-gaap	Revenues Revenues	1787902	USD
CY2016Q1	us-gaap	Revenues Revenues	1215089	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3807087	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4341119	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1395540	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1084696	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	5202627	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	5425815	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3414725	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4210726	USD
CY2015Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	275	USD
CY2016Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	10510	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	61681	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	66125	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-61406	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-55615	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-3476131	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-4266341	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3940	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-6157	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3480071	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4272498	USD
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14869746	shares
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	16537502	shares
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31604	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	572121	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	290586	USD
CY2016Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3929795	USD
CY2016Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	986	USD
CY2016Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	290586	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24802	USD
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	0	USD
CY2015Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	-929094	USD
CY2015Q1	capr	Increase Decrease From Grants Receivable IncreaseDecreaseFromGrantsReceivable	386002	USD
CY2016Q1	capr	Increase Decrease From Grants Receivable IncreaseDecreaseFromGrantsReceivable	91693	USD
CY2015Q1	capr	Increase Decrease In Prepaid And Other Current Assets IncreaseDecreaseInPrepaidAndOtherCurrentAssets	-32539	USD
CY2016Q1	capr	Increase Decrease In Prepaid And Other Current Assets IncreaseDecreaseInPrepaidAndOtherCurrentAssets	110818	USD
CY2015Q1	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	14135	USD
CY2016Q1	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	1000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1046681	USD
CY2016Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	693544	USD
CY2015Q1	capr	Increase Decrease In Accounts Payable And Accrued Expenses Related Party IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty	198987	USD
CY2016Q1	capr	Increase Decrease In Accounts Payable And Accrued Expenses Related Party IncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedParty	118535	USD
CY2016Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	65789	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1041667	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-911459	USD
CY2015Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	61707	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	96750	USD
CY2015Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	15487830	USD
CY2016Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2505572	USD
CY2015Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2016Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	8000000	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27455	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45808	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-15524758	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	5448620	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	16481217	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4930781	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8034765	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6939220	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	0	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	0	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6198148	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1095545	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	986	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	34999	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1000000	USD
CY2016Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.40
CY2016Q1	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	30000	USD
CY2016Q1	capr	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0	shares
CY2016Q1	capr	Class Of Warrant Or Right Exercised Weighted Average Exercise Price ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice	0
CY2016Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.01
CY2016Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1081903	shares
CY2016Q1	capr	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	0	shares
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.27
CY2016Q1	capr	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	0
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.59
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.23
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	290586	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	572121	USD
CY2016Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3900000	USD
CY2016Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M6D
CY2016Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	14300000	USD
CY2015Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	17957	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	240483	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	337233	USD
CY2016Q1	us-gaap	Payments For Royalties PaymentsForRoyalties	20000	EUR
CY2013Q4	capr	Additional Milestone Payments To Be Received Contingent Upon Exercise Of Options AdditionalMilestonePaymentsToBeReceivedContingentUponExerciseOfOptions	325000000	USD
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17952323	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17952323	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16254985	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16254985	shares
CY2016Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. Estimates also affect the reported amounts of revenues and expenses during the reporting period. The most sensitive estimates relate to the period over which collaboration revenue is recognized and the assumptions used to estimate stock-based compensation expense. Management uses its historical records and knowledge of its business in making these estimates. Accordingly, actual results may differ from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	43277	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4330	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2165	USD
CY2016Q1	us-gaap	Marketable Securities MarketableSecurities	2498425	USD
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7204078	shares
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6098330	shares
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12187	USD
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2016Q1	us-gaap	Depreciation Depreciation	19417	USD
CY2015Q1	us-gaap	Depreciation Depreciation	12615	USD
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17952323	shares
CY2016Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	538082	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	492274	USD
CY2016Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	193125	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	173708	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	36562	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	48749	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	43733	USD
CY2016Q1	capr	Class Of Warrant Or Right Granted ClassOfWarrantOrRightGranted	846073	shares
CY2016Q1	capr	Class Of Warrant Or Right Granted Weighted Average Exercise Price ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice	4.50
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	12086	USD
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.79	pure
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.82	pure
CY2016Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure

Files In Submission

Name	View Source	Status
0001144204-16-101913-index-headers.html	Edgar Link	pending
0001144204-16-101913-index.html	Edgar Link	pending
0001144204-16-101913.txt	Edgar Link	pending
0001144204-16-101913-xbrl.zip	Edgar Link	pending
capr-20160331.xml	Edgar Link	completed
capr-20160331.xsd	Edgar Link	pending
capr-20160331_cal.xml	Edgar Link	unprocessable
capr-20160331_def.xml	Edgar Link	unprocessable
capr-20160331_lab.xml	Edgar Link	unprocessable
capr-20160331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v438870_10q.htm	Edgar Link	pending
v438870_ex31-1.htm	Edgar Link	pending
v438870_ex31-2.htm	Edgar Link	pending
v438870_ex32-1.htm	Edgar Link	pending
v438870_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CAPR
CAPRICOR THERAPEUTICS, INC. Stock $capr

2016 Q1 Form 10-Q Financial Statement

#000114420416101913 Filed on May 13, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAPR CAPRICOR THERAPEUTICS, INC. Stock $capr

2016 Q1 Form 10-Q Financial Statement

#000114420416101913 Filed on May 13, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAPR
CAPRICOR THERAPEUTICS, INC. Stock $capr